Edwards Lifesciences Corp

Common Name
Edwards Lifesciences
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
15,800
Ticker
EW
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Edwards Lifesciences Corporation is a leading healthcare company primarily known for its innovative medical devices focused on cardiovascular conditions. The firm's primary function revolves around th...

Edwards Lifesciences's GHG Emissions Data Preview

In 2023, Edwards Lifesciences completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).

Edwards Lifesciences has also provided a category-level breakdown for 11 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Market-Based
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Location-Based
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Edwards Lifesciences's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Edwards Lifesciences amounted to 52,369 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Edwards Lifesciences decreased by 2.34%, showing that the company has made progress in taking action to reduce the climate impact of its operations.

Edwards Lifesciences's Scope 1 Emissions Over Time

20182019202020212022202305 k10 k15 k20 ktCO2e+9%+4%0%+25%-11%
  • Total Scope 1
  • Year-over-Year Change

What are Edwards Lifesciences's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Edwards Lifesciences were 16,120 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).

Has Edwards Lifesciences reduced its Scope 1 emissions over time?

Since 2018, Edwards Lifesciences's Scope 1 emissions have increased by 27.34%, reflecting a rising long-term trend in Scope 1 emissions over time.

Compared to the previous year (2022), Edwards Lifesciences's Scope 1 emissions decreased by 10.64%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.

What are Edwards Lifesciences's Scope 2 emissions?

In 2023, Edwards Lifesciences reported Scope 2 greenhouse gas (GHG) emissions of 23,783 tCOâ‚‚e using the market-based method, and 36,249 tCOâ‚‚e using the location-based method.

Has Edwards Lifesciences reduced its Scope 2 emissions over time?

Since 2018, Edwards Lifesciences's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have increased by 28.92%, reflecting a rising long-term trend in Scope 2 emissions over time.

Compared to the previous year (2022), Edwards Lifesciences's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Edwards Lifesciences 's emissions have plateaued with no significant change in its energy consumption footprint.

What methodology does Edwards Lifesciences use for Scope 2 reporting?

In 2023, Edwards Lifesciences reported its Scope 2 emissions using the market-based method and using the location-based method.

Edwards Lifesciences's Scope 2 Emissions Over Time

20182019202020212022202309.5 k19 k28.5 k38 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Edwards Lifesciences's Value Chain Emissions

In 2023, Edwards Lifesciences reported 571,975 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.

The 2023 disclosure of Edwards Lifesciences includes a breakdown across 11 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year.

Edwards Lifesciences's Scope 3 Emissions Over Time

2018201920202021202220230150 k300 k450 k600 ktCO2e+9%-39%+1248%+21%+12%
  • Total Scope 3
  • Year-over-Year Change

What are Edwards Lifesciences's Scope 3 emissions?

In 2023, Edwards Lifesciences reported total Scope 3 emissions of 571,975 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).

Approximately 95% of these emissions originated from upstream activities such as purchased goods and capital goods, while 5% came from downstream activities like product use, distribution, and end-of-life treatment.

Has Edwards Lifesciences reduced its Scope 3 emissions over time?

Since 2018, Edwards Lifesciences's Scope 3 emissions have increased by 1,111.71%, reflecting a rising long-term trend in Scope 3 emissions over time.

Compared to the previous year (2022), Edwards Lifesciences's Scope 3 emissions increased by 12.07%, suggesting that the company faced challenges in reducing emissions across its value chain.

What categories of Scope 3 emissions does Edwards Lifesciences disclose?

In 2023, Edwards Lifesciences reported emissions for 11 out of the 15 Scope 3 categories defined by the GHG Protocol.

This reflects a high level of granularity and transparency in the company's emissions reporting.

What are the main sources of Edwards Lifesciences's Scope 3 emissions?

In 2023, the largest contributors to Edwards Lifesciences's Scope 3 emissions were:

  • Purchased Goods and Services (Cat. 1): 411,283 tCOâ‚‚e (71.91%)
  • Business Travel (Cat. 6): 54,314 tCOâ‚‚e (9.5%)
  • Upstream Transportation and Distribution (Cat. 4): 32,808 tCOâ‚‚e (5.74%)

Edwards Lifesciences's Scope 3 Emissions by Categories

Purchased Goods andServices (Cat. 1)(71.9%)Business Travel(Cat. 6)(9.5%)UpstreamTransportation andDistribution(Cat. 4)(5.7%)

Insights into Edwards Lifesciences's Total Carbon Footprint

In 2023, Edwards Lifesciences reported a total carbon footprint of 624,344 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 10.7% increase compared to 2022, suggesting a rise in emissions across its operations or value chain.

The largest contributor to Edwards Lifesciences's total carbon footprint was Scope 3 emissions, accounting for 91.61% of the company's total carbon footprint, followed by Scope 2 emissions at 5.81%.

Want Full Access to Edwards Lifesciences's GHG Emissions Dataset?
Sign Up